SO
ALXN

STRS Ohio’s Alexion Pharmaceuticals ALXN Stock Holding History

STRS Ohio’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-44,242
Closed -$8.13M – 2380
2021
Q2 		$8.13M Buy
44,242
+6,440
+17% +$1.11M 0.03% 433
2021
Q1 		$5.78M Sell
37,802
-133,905
-78% -$20.7M 0.02% 473
2020
Q4 		$26.8M Sell
171,707
-75,916
-31% -$9.76M 0.1% 236
2020
Q3 		$28.3M Sell
247,623
-49,276
-17% -$5.32M 0.12% 195
2020
Q2 		$33.3M Sell
296,899
-71,142
-19% -$7.55M 0.15% 165
2020
Q1 		$33M Sell
368,041
-100,536
-21% -$9.87M 0.17% 137
2019
Q4 		$50.7M Sell
468,577
-165,672
-26% -$17.7M 0.21% 119
2019
Q3 		$62.1M Sell
634,249
-2,520
-0.4% -$284K 0.27% 90
2019
Q2 		$83.4M Sell
636,769
-2,959
-0.5% -$381K 0.37% 62
2019
Q1 		$86.5M Buy
639,728
+32,111
+5% +$3.99M 0.39% 59
2018
Q4 		$59.2M Buy
607,617
+10,792
+2% +$1.28M 0.3% 82
2018
Q3 		$83M Sell
596,825
-38,629
-6% -$4.85M 0.36% 59
2018
Q2 		$78.9M Buy
635,454
+61,971
+11% +$7.24M 0.34% 71
2018
Q1 		$63.9M Buy
573,483
+9,713
+2% +$1.16M 0.28% 105
2017
Q4 		$67.4M Buy
563,770
+5,832
+1% +$710K 0.29% 100
2017
Q3 		$78.3M Buy
557,938
+24,756
+5% +$3.36M 0.34% 75
2017
Q2 		$64.9M Sell
533,182
-3,230
-0.6% -$376K 0.29% 96
2017
Q1 		$65M Sell
536,412
-68,241
-11% -$8.8M 0.28% 96
2016
Q4 		$74M Sell
604,653
-7,265
-1% -$889K 0.33% 79
2016
Q3 		$75M Buy
611,918
+51,809
+9% +$6.67M 0.34% 71
2016
Q2 		$65.4M Buy
560,109
+52,710
+10% +$7.48M 0.29% 97
2016
Q1 		$70.6M Sell
507,399
-17,215
-3% -$2.53M 0.32% 81
2015
Q4 		$100M Buy
524,614
+105
+0% +$18.3K 0.45% 50
2015
Q3 		$82M Sell
524,509
-39,680
-7% -$7.24M 0.39% 58
2015
Q2 		$102M Sell
564,189
-16,042
-3% -$2.77M 0.45% 45
2015
Q1 		$101M Buy
580,231
+102,003
+21% +$18.5M 0.44% 48
2014
Q4 		$88.5M Sell
478,228
-83,526
-15% -$15.5M 0.38% 63
2014
Q3 		$93.2M Sell
561,754
-90,000
-14% -$14.8M 0.41% 60
2014
Q2 		$102M Buy
651,754
+182,436
+39% +$28.8M 0.45% 50
2014
Q1 		$71.4M Buy
469,318
+75,000
+19% +$11.9M 0.32% 83
2013
Q4 		$52.5M Buy
394,318
+76,800
+24% +$9.22M 0.24% 127
2013
Q3 		$36.9M Buy
317,518
+264,078
+494% +$29M 0.16% 178
2013
Q2 		$4.93M Buy
+53,440
New +$5.15M 0.02% 494

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

STRS Ohio's ALXN Position: Q3 2021 in Review

STRS Ohio sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 44,242 shares — an estimated $8.13M sold.

STRS Ohio first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $102M in Q2 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • STRS Ohio reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • STRS Ohio sold 44,242 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8.13M.
  • STRS Ohio first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • STRS Ohio's Alexion Pharmaceuticals position peaked at $102M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on STRS Ohio's 13F filing for Q3 2021, filed 22 Oct 2021.